Financhill
Back

Sarepta Therapeutics Quote, Financials, Valuation and Earnings

Sarepta Therapeutics Price Quote

$130.25
+0.06 (+1.46%)
(Updated: March 25, 2023 at 5:26 AM ET)

Sarepta Therapeutics Key Stats

Sell
47
Sarepta Therapeutics (SRPT) is a Sell

Day range:
$126.99 - $130.54
52-week range:
$61.28 - $159.84
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
12.22
P/B ratio:
29.76%

Volume:
969.1K
Avg. volume:
1.8M
1-year change:
61.85%
Market cap:
$11.5B
Revenue:
$933M
EPS:
$-8.03

How Much Does Sarepta Therapeutics Make?

Is Sarepta Therapeutics Growing As A Company?

  • What Is Sarepta Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.28%
  • What Is Sarepta Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Sarepta Therapeutics Stock Price Performance

What Is Sarepta Therapeutics 52-Week High & Low?

Sarepta Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sarepta Therapeutics?

Is Sarepta Therapeutics Cash Flow Positive?

  • What Is SRPT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$325.3M
  • What Is Sarepta Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $232.5M
  • What Is Sarepta Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1B

Sarepta Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    SRPT return on invested capital is -36.22%
  • What Is Sarepta Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -22.71%
  • What Is SRPT Return On Equity?
    ROE is a measure of profitability and is -105.72%

Sarepta Therapeutics Earnings Date & Stock Price

Sarepta Therapeutics Competitors

Sarepta Therapeutics Dividend Yield

Data Unavailable

Sarepta Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 40.57%
Revenue: 28.28% 3.16%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 170.42
Upside from Last Price: 30.9%

Major Shareholders

  • How many SRPT shares are owned by institutional investors?
    117M SRPT shares are owned by institutional investors
  • How many SRPT shares are owned by insiders?
    15.5M SRPT shares are owned by insiders